Drawing for PROSTAVISION

USPTO serial 79332912

PROSTAVISION

Reviewed by CopyMark Law Group

Filing date
Status date
Registration date
—
Examiner
CARR, PATRICK C
Law office
TMO LAW OFFICE 125 - EXAMINING ATTORNEY ASSIGNED

What this means

These status codes mean the trademark application is abandoned and no longer pending. Common reasons include missing an Office Action response (600), filing without a valid basis (602), express abandonment by the applicant (604), or failure to respond to an examiner's inquiry (618). Revival may be possible in limited circumstances. If abandonment was unintentional, consult counsel about a petition to revive. Otherwise file a new application if protection is still needed.

Status 602: These status codes mean the trademark application is abandoned and no longer pending. Common reasons include missing an Office Action response (600), filing without a valid basis (602), express abandonment by the applicant (604), or failure to respond to an examiner's inquiry (618). Revival may be possible in limited circumstances.

Need help with PROSTAVISION?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Philip C. Schroeder

Philip C. Schroeder Buchalter18400 Von Karman Ave., Suite 800Irvine, CA 92612UNITED STATES

Goods and services

ClassDescriptionStatusFirst use
005Medical and veterinary preparations for the diagnosis of diseases of the prostate; medical and veterinary preparations for the treatment of diseases of the prostate; medical and veterinary preparations for the diagnosis of cancer; medical and veterinary preparations for the treatment of cancer; dietetic foods and beverages for medical or veterinary purposes; chemical preparations for medical or pharmaceutical purposes for the diagnosis of diseases of the prostate; chemical preparations for medical or pharmaceutical purposes for the treatment of diseases of the prostate; chemical preparations for medical or pharmaceutical purposes for the diagnosis of cancer; chemical preparations for medical or pharmaceutical purposes for the treatment of cancer; biological preparations for medical or pharmaceutical purposes for the diagnosis of diseases of the prostate; biological preparations for medical or pharmaceutical purposes for the treatment of diseases of the prostate; biological preparations for medical or pharmaceutical purposes for the diagnosis of cancer; biological preparations for medical or pharmaceutical purposes for the treatment of cancer; preparations for use in medical diagnostic processes; preparations for use in medical diagnostic processes relating to the diagnosis of diseases of the prostate; preparations for use in medical diagnostic processes relating to the diagnosis of cancerACTIVE—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Dec 5, 2025LIMGLIMITATION OF GOODS RECEIVED FROM IB—
Feb 7, 2024MAB2ABANDONMENT NOTICE E-MAILED - FAILURE TO RESPONDThe trademark application was abandoned because a required response or document was not filed by the deadline — usually a missed Office Action response. The application is dead unless a petition to revive is granted within a limited time.
Feb 7, 2024ABN2ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSEThe trademark application was abandoned because a required response or document was not filed by the deadline — usually a missed Office Action response. The application is dead unless a petition to revive is granted within a limited time.
Jul 31, 2023OPNXNOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB—
Jul 26, 2023GNFNNOTIFICATION OF FINAL REFUSAL EMAILED—
Jul 26, 2023GNFRFINAL REFUSAL E-MAILEDA final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon.
Jul 26, 2023CNFRFINAL REFUSAL WRITTENA final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon.
Jul 15, 2023RCCKSUSPENSION CHECKED - TO ATTORNEY FOR ACTION—
Jul 12, 2023OPNSNOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB—
Jul 12, 2023OPNRNOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB—
Jun 22, 2023RCCKSUSPENSION CHECKED - TO ATTORNEY FOR ACTION—
Jun 21, 2023RCCKSUSPENSION CHECKED - TO ATTORNEY FOR ACTION—
Dec 5, 2022GNS3NOTIFICATION OF LETTER OF SUSPENSION E-MAILED—
Dec 5, 2022GNSLLETTER OF SUSPENSION E-MAILED—
Dec 5, 2022CNSLSUSPENSION LETTER WRITTEN—
Nov 2, 2022TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Nov 2, 2022CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Nov 2, 2022TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
May 25, 2022RFNTREFUSAL PROCESSED BY IB—
May 2, 2022RFCSNON-FINAL ACTION MAILED - REFUSAL SENT TO IB—
May 2, 2022RFRRREFUSAL PROCESSED BY MPU—
Mar 19, 2022RFCRNON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW—
Mar 18, 2022CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Mar 8, 2022DOCKASSIGNED TO EXAMINER—
Feb 22, 2022MAFRAPPLICATION FILING RECEIPT MAILED—
Feb 17, 2022NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Feb 16, 2022LIMILIMITATION FROM ORIGINAL APPLICATION ENTERED—
Feb 10, 2022REPRSN ASSIGNED FOR SECT 66A APPL FROM IB—

Frequently asked questions

Related guidance